A Russian university has claimed the clinical trials of the world's first vaccine against the coronavirus disease on volunteers have been completed successfully.
The Sechenov First Moscow State Medical University said it began clinical trials of the vaccine against coronavirus on June 18. The vaccine was produced by Russia's Gamaleya Institute of Epidemiology and Microbiology.
The news about the completion of the tests on volunteers was declared by Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector - Borne Disease at Sechenov University.
Chief researcher Elena Smolyarchuk who heads the center for clinical research on medications at sechenov university, told Russian news agency Tass on Sunday that the research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20.
Russia had allowed clinical trials of two forms of a potential covid 19 vaccine, the first vaccine in the form of solution for intramuscular administration, was carried out at the burdenko military hospital.
Another vaccine in the form of powder for the preparation of a solution for intramuscular administration was carried out at sechenov first Moscow state medical university.
The first state of research on the vaccine at sechenov university involved a group of 18 volunteers and the second group involved 20 volunteers.
Earlier results of the covid 19 vaccine tests performed on a group of volunteers in Russia showed that they were developing immunity to the coronavirus.
The data obtained by the gamaleya national research center for epidemiology and microbiology, proves that volunteers of the first and second group are forming an immune response after injections of the vaccine against the coronavirus, according to an earlier statement from the Russian defense ministry.